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-1.1 -1. : 1 1 Portions of this document may be illegible in electronic image products. Images are produced from the best available original document. Recent experiments in this laboratory (1) and that of Radin (2) have demonstrated the existence, in the mammalian brain, of a system of alpha oxidation or one-carbon degradation of the long-chain fatty acids. In vitro studies (3, 4, 5, 6) have indicated that this enzymatic activity is concentrated in the microsomal fraction (or the 110,000xg precipitate) and that it requires the 110,000xg supernatant and certain other cofactors, including oxygen. Unpublished experiments from this laboratory have shown · that the only required additive is ferrous ion and that the supernatant factor is indeed ascorbic acid, as had been suspected by Levis (7) .
In view of this information and as a further test of the function of ascorbic acid as the true cofactor in vivo, it was considered of interest to test for alpha oxidation activity in the brains of scorbutic as compared with ascorbic acid supplemented guinea pigs.
MATERIALS AND METHODS
Animals Six 275 g guinea pigs were raised on an ascorbic acid-I:· ·rr I deficient diet (Nutritional Biochemicals) with ascorbic acid (30-50 mg/100 ml) included in the drinking water of 3 of the animals designated controls.
With an average water consumption of 100 ml, each of the control animals received 30 mg of ascorbic acid daily. After 10 days, the experimental Animals had begun to show signs of ascorbic acid deficiency (weight loss, tenderness of the joints, unkempt coat) whereas the controls appeared completely normal. At this time one control and one experimental animal were sacrificed. After 14 days a second pair was used. The brains, which weighed the same in control and experimental animals, were homogenized in about 10 volumes of 0.25 M sucrose solution buffered to p11 7.4 with .01 M phosphate buffer. The homogenate thus produced was centrifuged at 1000xg, the precipitate was discarded and the·supernatant suspension was centrifuged for 0.5 hours at 10,000xg. This supernatant (S4) was used directly for enzymatic studies or was centrifuged at 110,000xg. The supernatant, S5, and pellet P5, from this centrifugation were recombined in equal volumes for enzyme studies.
14 Materials Cerebronic acid-1-C was synthesized by a procedure #0 be described elsewhere. It was better than 94% pure by TLC and GLC, the impurities consisting of small percentages of neighboring homologs. .For homogeneous and remained so until it was frozen following the experiment.
Thawing and sonication served to clarify it before each use.
Other chemicals and solvents were reagent grade and were used without further purification.
Methods The procedures for carrying out the enzymatic reactions and -· rs"--r.Z-14 for collecting and counting the C02 have been described previously (4). Quantitative determination of ascorbic acid in the $5 fractions was carried out using a modification of the method of Roe et al· (8) . Table I shows the radioactivity of the carbon dioxide collected from incubations of the S4 fractions of scorbutic and control guinea pig brains.
RESULTS
It can be seen that there is very little activity in the scorbutic brain -5 preparation as compared to the control. The presence of 5.8x10 M ascorbic acid in the scorbutic incubation brought the activity to normal, whereas it had little effect on the control homogenate.
In Table II are shown the comparisons of different combinations of the P5 and S5 fractions from control and scorbutic guinea pigs. As might be expected, the combined fractions from the control brains were the most active. Almost as active is the scorbutic P5 and control S5 combination whereas those combinations with scorbutic S5 fractions had relatively low activity.
Analysis of the ascorbic acid concentrations in the S5 fractions revealed 20 gg/ml for the controls, 4 Bg/ml for the 10 day scorbutic animal and 10 tig/ml for the 14 day scorbutic animal.
DISCUSSION
Although the above experiments do not constitute incontrovertible evidence that ascorbic acid is the natural cofactor for alpha oxidation, it is strongly indicative. It might be argued that ascorbic acid has heen shown to be active in the in vitro alpha oxidation system and that it has been known for some time that the brain, in common with certain other tissues, normally has a relatively high ascorbic acid concentration. ,
However, it seems to be more than coincidental that in preparations from the brains of scorbutic guinea pigs, alpha oxidation is reduced and that it is restored maximally by ascorbic acid concentrations in the same range as is normally found in the brain. That the failure of alpha oxidation in the scorbutic brain is due simply to a lack of ascorbic acid is evident from the fact that the P5, or microsomal, fraction is active and that the loss is in the S5 fraction, in which the ascorbic acid is found (5) . In confirmation of this idea is the finding that the ascorbic acid content of the S5 from the 10-day scorbutic guinea pig was 20% of normal while '
that from the 14-day scorbutic animal was 50% of normal. It is interesting that the decrease in alpha oxidation activity of the S4 fractions is roughly proportional to these values. The implications of these results
are not yet clear, but it seems evident that alpha oxidation represents yet another oxidase reaction in which ascorbic acid is a cofactor. Present experiments designed to elucidate the mechanism of the in vitro·reac-tion may shed light on the function of the in vivo readtion as well. Incubations were for one hour at 370 C.followed by addition of 0.2 ml hyamine solution in the cup and 0.2 ml, 9N H2S04 to the homogenate and 1.5 hours further incubation at room temperature. Incubations were as described for Table I except that 1 ml each of P5 and S5 were substituted for 1.5 ml of S4. 
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